Scale-Up for NDDS Products MCQs With Answer

Scale-Up for NDDS Products MCQs With Answer

Introduction: Scaling up novel drug delivery systems (NDDS) from laboratory to commercial production demands a deep understanding of formulation science, process engineering and regulatory expectations. This quiz collection focuses on technical and practical aspects of scale-up and technology transfer—covering critical quality attributes (CQAs), critical process parameters (CPPs), equipment scale-up rules, process analytical technology (PAT), aseptic processing, and validation strategies. Designed for M.Pharm students, these MCQs aim to strengthen your ability to anticipate scale-up challenges, design robust scale-up/scale-down models, and apply QbD principles to ensure product quality and regulatory compliance during tech transfer.

Q1. What is the primary objective when scaling up an NDDS manufacturing process?

• To reduce production costs
• To reproduce critical quality attributes and performance at commercial scale
• To shorten development timelines
• To increase batch size regardless of product quality

Correct Answer: To reproduce critical quality attributes and performance at commercial scale

Q2. Which of the following is typically classified as a Critical Process Parameter (CPP) rather than a Critical Quality Attribute (CQA)?

• Particle size distribution
• Drug content uniformity
• Agitator RPM during mixing
• pH of the final product

Correct Answer: Agitator RPM during mixing

Q3. Which scale-up rule is most appropriate to preserve mixing intensity under turbulent conditions?

• Maintain constant tip speed (m/s)
• Maintain constant power per unit volume (P/V)
• Maintain constant impeller Reynolds number
• Maintain constant impeller diameter

Correct Answer: Maintain constant power per unit volume (P/V)

Q4. Geometric similarity in scale-up of stirred tanks means which of the following?

• Using the same impeller rotational speed at all scales
• Keeping the same ratios of tank and impeller dimensions (D/T, d/D, off-bottom clearance)
• Keeping the same power input in kilowatts
• Maintaining the same fluid volume only

Correct Answer: Keeping the same ratios of tank and impeller dimensions (D/T, d/D, off-bottom clearance)

Q5. For aseptic filling of NDDS products, which validation activity is considered critical to demonstrate aseptic performance?

• Stability indicating assay
• Media fill (aseptic process simulation)
• Particle size analysis
• Visual inspection of labels

Correct Answer: Media fill (aseptic process simulation)

Q6. Which PAT (Process Analytical Technology) tool is commonly used for inline moisture and content monitoring during continuous NDDS processing?

• Offline HPLC with manual sampling
• NIR spectroscopy with multivariate models
• Optical microscopy
• Titration analysis

Correct Answer: NIR spectroscopy with multivariate models

Q7. What is the main purpose of developing a scale-down model for an NDDS process?

• To reduce raw material consumption in production
• To allow laboratory staff to practice procedures
• To replicate large-scale critical behaviors and failure modes for development and troubleshooting
• To avoid regulatory submissions

Correct Answer: To replicate large-scale critical behaviors and failure modes for development and troubleshooting

Q8. Residence time distribution (RTD) studies are most important for which type of NDDS manufacturing process?

• Batch granulation processes only
• Continuous manufacturing processes such as continuous coating or flow reactors
• Manual filling in syringes
• Packaging line speed optimization only

Correct Answer: Continuous manufacturing processes such as continuous coating or flow reactors

Q9. Which major physical phenomenon often becomes a limiting factor when moving from lab to plant scale for heat-sensitive NDDS formulations?

• Improved solubility at large scale
• Changes in heat and mass transfer leading to non-uniform drying or overheating
• Reduction in raw material impurity
• Increased regulatory oversight

Correct Answer: Changes in heat and mass transfer leading to non-uniform drying or overheating

Q10. In lyophilization scale-up of a sterile NDDS, which challenge most critically affects primary drying time and product integrity?

• Color change of the product
• Differences in heat transfer between lab and production shelves affecting sublimation rate
• Excessive headspace gas composition
• Label design

Correct Answer: Differences in heat transfer between lab and production shelves affecting sublimation rate

Q11. When scaling up spray drying for NDDS microparticles, which variable is most critical to control to obtain similar particle morphology?

• Spray nozzle color
• Inlet temperature only
• Droplet size distribution and drying gas residence time
• Batch numbering system

Correct Answer: Droplet size distribution and drying gas residence time

Q12. For scale-up of liposomal formulations using high-pressure homogenization, which parameter is most influential on final vesicle size?

• Packaging container color
• Lipid bilayer chemical composition only
• Homogenization pressure and number of passes
• Ambient lighting during processing

Correct Answer: Homogenization pressure and number of passes

Q13. Which type of process validation is typically performed before routine commercial manufacture of a newly scaled-up NDDS?

• Concurrent validation only
• Prospective validation (executed prior to release of commercial batches)
• Retrospective validation only
• No validation required if lab data looks good

Correct Answer: Prospective validation (executed prior to release of commercial batches)

Q14. A comprehensive technology transfer package should at minimum include which of the following?

• Master batch record and manufacturing procedure only
• Process flow diagram and QC tests only
• Technology transfer report including process description, critical parameters and acceptance criteria
• Regulatory submission only

Correct Answer: Technology transfer report including process description, critical parameters and acceptance criteria

Q15. In Quality by Design (QbD) for manufacturing NDDS, the term that defines the multidimensional combination of input variables that assures product quality is:

• Control strategy
• Design space
• Critical quality attribute
• Acceptance criteria

Correct Answer: Design space

Q16. Which definition best describes a Critical Process Parameter (CPP)?

• A parameter that is easy to measure but irrelevant to product quality
• A process input that has no effect on CQAs
• A process parameter whose variability has an impact on a CQA and should be controlled
• A final product test performed by QC

Correct Answer: A process parameter whose variability has an impact on a CQA and should be controlled

Q17. For scale-up of mixing under laminar flow conditions, which scaling criterion is most appropriate to preserve flow characteristics?

• Maintain constant power per unit volume (P/V)
• Maintain constant Reynolds number
• Maintain constant impeller diameter in meters
• Maintain constant batch size

Correct Answer: Maintain constant Reynolds number

Q18. A commonly accepted practical cleaning validation acceptance limit used by many manufacturers to prevent cross-contamination is:

• 1% of the previous batch active substance on cleaned surfaces
• 1/1000 of the minimum therapeutic dose or 10 ppm, whichever is lower
• No detectable trace by any analytical method
• 10% of the specification limit of the drug substance

Correct Answer: 1/1000 of the minimum therapeutic dose or 10 ppm, whichever is lower

Q19. During technology transfer for a modified-release NDDS, regulators expect demonstration of what to approve the change in manufacturing scale?

• Only analytical method validation
• Comparability studies showing equivalent CQAs and performance between scales
• Only pilot plant photos
• Only vendor qualification

Correct Answer: Comparability studies showing equivalent CQAs and performance between scales

Q20. For a scale-down model to be acceptable for process validation and failure investigations, it must be:

• Smaller and cheaper without further justification
• Characterized and demonstrated to reproduce critical unit operation behaviors and CQAs of the commercial process
• Identical in every dimension to the full scale equipment
• Used only for training, not for investigation

Correct Answer: Characterized and demonstrated to reproduce critical unit operation behaviors and CQAs of the commercial process

Download